Cancer pathway process can be streamlined with the adoption of AI and automation

Medicine is a constantly evolving science where small changes can have a huge impact on the lives of patients. When it comes to a cancer diagnosis and treatment, every minute counts. According to European Commission estimates, the cancer incidence by 2040 will impact just over three million people a year. By significantly reducing treatment and recovery times with the help of technology, healthcare organizations will be able to provide better and more compassionate care with the resources they have available.

Current cancer care is driven by manual processes from start to finish. Diagnostic tests – including laboratory and biopsies, pathology, and imaging services – are characterized by large volumes of paperwork and data handling. Ensuring each step is meticulously followed without hinderance and accompanied by the relevant information is vital for patient conferences or specialist consultations.

By adopting automation, artificial intelligence, and digital workers into the cancer pathway, is technology the right solution to benefit patients, healthcare teams and healthcare organizations?

This viewpoint will go on to discuss:

  • The cancer pathway process
  • How IA can improve time to diagnosis
  • How digital works can increased speed and accuracy
  • The future of oncology therapies
  • The benefits of automation in outpatient discharge

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer